Literature DB >> 21142864

Genetics of gestational trophoblastic neoplasia: an update for the clinician.

Constantine Alifrangis1, Michael J Seckl.   

Abstract

Gestational trophoblastic disease is a spectrum of disorders ranging from premalignant hydatidiform moles through to malignant invasive moles, choriocarcinoma and rare placental site trophoblastic tumor. The latter are often collectively referred to as gestational trophoblastic tumors or neoplasia (GTN). Although most women can expect to be cured of their disease, many interesting questions arise in the management of gestational trophoblastic disease. Current issues pertain to diagnosis of GTN, predicting progression from hydatidiform moles to GTN and the emergence of drug resistance in GTN. Our understanding of the genetics of GTN has helped us answer some of these questions but many remain unresolved. This article seeks to address recent advances in the genetics of GTN in relation to diagnosis, etiology, prognosis and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 21142864     DOI: 10.2217/fon.10.153

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  6 in total

1.  Unilateral hydronephrosis caused by invasive mole: a case report.

Authors:  Hai-Yan Zhang; Wei Wu; Jin Zhu
Journal:  Int J Clin Exp Med       Date:  2013-10-25

Review 2.  Prediction of Neoplastic Transformation of Hydatidiform Mole: Current Evidence.

Authors:  Mohamed Laban; Seif Tarek El-Swaify; Mazen A Refaat; E A Ibrahim; Rehab M Abdelrahman
Journal:  Reprod Sci       Date:  2021-08-02       Impact factor: 3.060

3.  Crosstalk between the p38 and TGF-β signaling pathways through TβRI, TβRII and Smad3 expression in plancental choriocarcinoma JEG-3 cells.

Authors:  Yusi Tan; Qian Xu; Yuhong Li; Xiaodan Mao; Kongyan Zhang
Journal:  Oncol Lett       Date:  2014-06-16       Impact factor: 2.967

Review 4.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

5.  ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma.

Authors:  Marina Georgiou; Panagiota Ntavelou; William Stokes; Rajat Roy; Geoffrey J Maher; Tsvetana Stoilova; Josephine A M Y Choo; Callum P Rakhit; Miguel Martins; Paul Ajuh; Neil Horowitz; Ross S Berkowitz; Kevin Elias; Michael J Seckl; Olivier E Pardo
Journal:  Oncogene       Date:  2022-03-18       Impact factor: 8.756

6.  A metastatic invasive mole arising from iatrogenic uterus perforation.

Authors:  Yuanming Shen; Xiaoyun Wan; Xing Xie
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.